⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22042226 | 0.92 | — | — | |
| SCHEMBL23803919 | 0.82 | — | — | |
| SCHEMBL3950307 | 0.82 | — | — | |
| SCHEMBL31296255 | 0.78 | — | — | |
| SCHEMBL628561 | 0.72 | — | — | |
| SCHEMBL9465029 | 0.72 | ZDHHC7 (0.48) | — | |
| SCHEMBL611894 | 0.71 | — | — | |
| SCHEMBL31284200 | 0.71 | DNM1 (0.41) | — | |
| SCHEMBL807201 | 0.71 | DNM1 (0.41) | — | |
| SCHEMBL16908582 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4562019-A1 | IP5 SUBSTITUTED COMPOUNDS | Sanifit Therapeutics S.A. (ES) | 2025-06-04 | — | — | EP | disclosed |
| EP-4561585-A1 | IP4-4,6 SUBSTITUTED DERIVATIVE COMPOUNDS FOR USE IN THE TREATMENT, INHIBITION OF PROGRESSION, AND PREVENTION OF ECTOPIC CALCIFICATION | Sanifit Therapeutics S.A. (ES) | 2025-06-04 | — | — | EP | disclosed |
| CN-119630679-A | IP5 substituted compounds | 萨尼菲特治疗有限公司 | 2025-03-14 | — | — | CN | disclosed |
| WO-2024023359-A1 | IP4-4,6 SUBSTITUTED DERIVATIVE COMPOUNDS FOR USE IN THE TREATMENT, INHIBITION OF PROGRESSION, AND PREVENTION OF ECTOPIC CALCIFICATION | SANIFIT THERAPEUTICS, S.A. (ES) | 2024-02-01 | — | — | WO | disclosed |
| WO-2024023360-A1 | IP5 SUBSTITUTED COMPOUNDS | SANIFIT THERAPEUTICS, S.A. (ES) | 2024-02-01 | — | — | WO | disclosed |
| EP-4284809-A1 | IP4-4,6 SUBSTITUTED DERIVATIVE COMPOUNDS | Sanifit Therapeutics S.A. (ES) | 2023-12-06 | — | — | EP | disclosed |
| WO-2022162206-A1 | IP4-4,6 SUBSTITUTED DERIVATIVE COMPOUNDS | SANIFIT THERAPEUTICS, S.A. (ES) | 2022-08-04 | — | — | WO | disclosed |
| EP-2950649-A2 | AMINE COMPOUNDS HAVING ANTI-INFLAMMATORY, ANTIFUNGAL, ANTIPARASITIC AND ANTICANCER ACTIVITY | Wellstat Therapeutics Corporation (US) | 2015-12-09 | — | — | EP | disclosed |
| EP-2836539-A1 | MATERIALS COATED WITH CALIXARENES | Université Libre de Bruxelles (ULB) (BE) | 2015-02-18 | — | — | EP | disclosed |
| WO-2014120995-A2 | AMINE COMPOUNDS HAVING ANTI-INFLAMMATORY, ANTIFUNGAL, ANTIPARASITIC AND ANTICANCER ACTIVITY | WELLSTAT THERAPEUTICS CORPORATION (US) | 2014-08-07 | — | — | WO | disclosed |
| WO-2009157527-A1 | BENZOTHIAZOLE CARBOXAMIDES AS FUNGICIDES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-12-30 | — | — | WO | disclosed |
| EP-1582524-B1 | Method of preparing organomagnesium compounds | UNIV MUENCHEN L MAXIMILIANS (DE) | 2008-08-13 | — | — | EP | disclosed |
| US-7387751-B2 | Method of preparing organomagnesium compounds | LUDWIG-MAXIMILIANS-UNIVERSITAT MUNCHEN (DE) | 2008-06-17 | — | — | US | disclosed |
| US-7384580-B2 | Method of preparing organomagnesium compounds | LUDWIG-MAXIMILIANS-UNIVERSITAT MUNCHEN (DE) | 2008-06-10 | — | — | US | disclosed |
| US-20070194468-A1 | Method of preparing organomagnesium compounds | LUDWIG-MAXIMILIANS-UNIVERSITAT MUNCHEN (DE) | 2007-08-23 | — | — | US | disclosed |
| US-20050218532-A1 | Method of preparing organomagnesium compounds | LUDWIG-MAXIMILIANS-UNIVERSITAT MUNCHEN (DE) | 2005-10-06 | — | — | US | disclosed |
| EP-1582524-A1 | Method of preparing organomagnesium compounds | Ludwig Maximilians Universität (DE) | 2005-10-05 | — | — | EP | disclosed |
| EP-1582523-A1 | Method of preparing organomagnesium compounds | Ludwig-Maximilians-Universität München (DE) | 2005-10-05 | — | — | EP | disclosed |
| EP-0679152-A1 | ANTI-ANDROGENIC CYCLO AND BICYCLO ALKENES. | LAFOR LAB LTD (US) | 1995-11-02 | — | — | EP | disclosed |
| WO-1994015900-A1 | ANTI-ANDROGENIC CYCLO AND BICYCLO ALKENES | LAFOR LABORATORIES LIMITED (US) | 1994-07-21 | — | — | WO | disclosed |